These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 1451590)

  • 1. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry.
    Baldetorp B; Fernö M; Fallenius A; Fallenius-Vecchi G; Idvall I; Olsson H; Sigurdsson H; Akerman M; Killander D
    Cytometry; 1992; 13(6):577-85. PubMed ID: 1451590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates.
    Baldetorp B; Bendahl PO; Fernö M; Alanen K; Delle U; Falkmer U; Hansson-Aggesjö B; Höckenström T; Lindgren A; Mossberg L
    Cytometry; 1995 Jun; 22(2):115-27. PubMed ID: 7587742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA ploidy and S-phase fraction by image and flow cytometry in breast cancer fine-needle cytopunctures.
    Spyratos F; Briffod M
    Mod Pathol; 1997 Jun; 10(6):556-63. PubMed ID: 9195572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study.
    Strang P; Stenkvist B; Bergström R; Stendahl U; Valdes del Campo M; Tribukait B
    Anticancer Res; 1991; 11(2):783-8. PubMed ID: 2064334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA analysis in advanced breast cancer.
    Leivonen M; Krogerus L; Nordling S
    Cancer Detect Prev; 1994; 18(2):87-96. PubMed ID: 8025900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients.
    Dreinhöfer KE; Baldetorp B; Akerman M; Fernö M; Rydholm A; Gustafson P
    Cytometry; 2002 Feb; 50(1):19-24. PubMed ID: 11857594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns.
    Michels JJ; Marnay J; Plancoulaine B; Chasle J
    Cytometry B Clin Cytom; 2004 May; 59(1):32-9. PubMed ID: 15108168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer].
    Winter K; Eidtmann H; Jonat W
    Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
    Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
    Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study.
    Lee KH; Lee JS; Lee JH; Kim SW; Suh C; Kim WK; Kim SH; Min YI; Kim BS; Park KC; Lee MS; Sun HS
    Br J Cancer; 1999 Apr; 79(11-12):1727-35. PubMed ID: 10206284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? The Swedish Society of Cancer Study Group.
    Baldetorp B; Stål O; Ahrens O; Cornelisse C; Corver W; Falkmer U; Fernö M
    Cytometry; 1998 Dec; 33(4):385-93. PubMed ID: 9845432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of semi-automated cell cycle analysis of flow cytometric DNA-histograms of fresh breast cancer material.
    Bergers E; van Diest PJ; Baak JP
    Anal Cell Pathol; 1995 Jan; 8(1):1-13. PubMed ID: 7734408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA analysis and S-phase fraction determination by flow cytometric analysis of infiltrating lobular carcinoma of the breast.
    Frost AR; Karcher DS; Terahata S; Siegel RS; Silverberg SG
    Mod Pathol; 1996 Sep; 9(9):930-7. PubMed ID: 8878026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
    Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
    Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.